Safety and Efficacy of Atezolizumab and Bevacizumab Combination as a First Line Treatment of Advanced Hepatocellular Carcinoma

Valentina Zanuso,1,2 Angelo Pirozzi,1,2 Rita Balsano,2 Tiziana Pressiani,2 Lorenza Rimassa1,2 1Department of Biomedical Sciences, Humanitas University, Milan, Italy; 2Medical Oncology and Hematology Unit, IRCCS Humanitas Research Hospital, Milan, ItalyCorrespondence: Lorenza Rimassa, Humanitas Unive...

Descripció completa

Dades bibliogràfiques

Autors principals:	Zanuso V, Pirozzi A, Balsano R, Pressiani T, Rimassa L
Format:	Artigo
Idioma:	Inglês
Publicat:	Dove Medical Press 2023-10-01
Col·lecció:	Journal of Hepatocellular Carcinoma
Matèries:	hcc immune checkpoint inhibitors atezolizumab bevacizumab safety efficacy.
Accés en línia:	https://www.dovepress.com/safety-and-efficacy-of-atezolizumab-and-bevacizumab-combination-as-a-f-peer-reviewed-fulltext-article-JHC
Etiquetes:	Afegir etiqueta Sense etiquetes, Sigues el primer a etiquetar aquest registre!